Plus de 40 ans d’expérience à votre service

Tel. : 01 45 33 67 17 / E-mail : coger@coger.fr

Stock épuisé.
En rupture de stock
Quantité minimum d'achat
La quantité minimum d'achat n'est pas atteinte

 

 

100 µg

Ref. AG-27B-0005-C100
ADIPOGEN LIFE SCIENCES

photos non contractuelles

Neuf 300.00 270.00 H.T.

Quantité

Alerte réapprovisionnement
Recevez une alerte par email dès que votre choix sera de retour en stock
Votre e-mail*:

Détails Produit

Product description: Recombinant Antibody. Recognizes mouse, bovine and human alpha-tubulin. Species cross-reactivity: Bovine, Human, Mouse. Clone: F2C. Isotype: Human IgG2lambda. Applications: ICC, WB. Host: Purified from HEK 293 cell culture supernatant. Liquid. In PBS containing 10% glycerol and 0.02% sodium azide. Tubulin is the major building block of microtubules. This intracellular cylindrical filamentous structure is present in almost all eukaryotic cells. Microtubules function as structural and mobile elements in mitosis, intracellular transport, flagellar movement, and the cytoskeleton.

Alternate Names/Synonyms:

Product Type: Recombinant Antibody

Clone: F2C

Isotype: Human IgG2lambda

Immunogen: Bovine brain tubulin.

Applications: ICC, WB

Species Crossreactivity: Bovine, Human, Mouse

Specificity: Recognizes mouse, bovine and human alpha-tubulin.

Purity: >95% (SDS-PAGE)

Concentration: 1mg/ml

Formulation: Liquid. In PBS containing 10% glycerol and 0.02% sodium azide.

Short Term Storage: +4°C

Long Term Storage: -20°C

Shipping: BLUE ICE

Use & Stability: Stable for at least 1 month after receipt when stored at +4°C. Stable for at least 1 year after receipt when stored at -20°C.

Lien vers la Fiche Technique

Literature References: Recombinant antibodies selected against subcellular fractions to track endogenous protein dynamics in vivo: C. Nizak, et al.; Traffic 7, 739 (2003) | Characterization of single chain antibody targets through yeast two hybrid: O. Vielemeyer, et al; BMC Biotechnol. 10, 59 (2010) | AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity: A. Di Micco, et al.; PNAS 113, e4671 (2016) | Pharmacological eEF2K activation promotes cell death and inhibits cancer progression: A. De Gassart, et al.; EMBO Reports 17, 1471 (2016)